{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-061203","form_type":"8-K","ticker":"TOVX","cik":"0000894158","company_name":"Theriva Biologics, Inc.","filed_at":"2025-06-20T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.697087+00:00","generated_at":"2026-05-19T02:20:36.024259+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Theriva Biologics files $2.5M at-the-market equity offering through A.G.P.","bullets":["Up to $2,534,352 of common stock registered for sale via ATM method with A.G.P./Alliance Global Partners.","Sales agent commission rate set at up to 3.0% of gross proceeds per share sold.","No minimum sale requirement; agent uses commercially reasonable efforts on a principal or agency basis.","Proceeds will be used for general corporate purposes; no escrow or trust arrangement."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-061203","json":"https://secwatch.observer/filing/0001104659-25-061203.json","markdown":"https://secwatch.observer/filing/0001104659-25-061203.md","text":"https://secwatch.observer/filing/0001104659-25-061203.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/0001104659-25-061203-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/894158/000110465925061203/tm2518362d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T02:20:36.024259+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}